SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-028036
Filing Date
2022-08-04
Accepted
2022-08-04 16:59:35
Documents
81
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sana-10q_20220630.htm   iXBRL 10-Q 3912612
2 EX-10.1 sana-ex101_314.htm EX-10.1 392573
3 EX-10.2 sana-ex102_295.htm EX-10.2 20870
4 EX-31.1 sana-ex311_7.htm EX-31.1 21308
5 EX-31.2 sana-ex312_6.htm EX-31.2 19853
6 EX-32.1 sana-ex321_8.htm EX-32.1 9774
7 EX-32.2 sana-ex322_9.htm EX-32.2 9486
8 GRAPHIC ga1rvcgqctsv000001.jpg GRAPHIC 106964
9 GRAPHIC grdb4xwsxiff000001.jpg GRAPHIC 74055
  Complete submission text file 0001564590-22-028036.txt   13844459

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA sana-20220630.xsd EX-101.SCH 59549
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sana-20220630_cal.xml EX-101.CAL 56782
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sana-20220630_def.xml EX-101.DEF 227354
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE sana-20220630_lab.xml EX-101.LAB 474715
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sana-20220630_pre.xml EX-101.PRE 400391
75 EXTRACTED XBRL INSTANCE DOCUMENT sana-10q_20220630_htm.xml XML 2888910
Mailing Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39941 | Film No.: 221137545
SIC: 2836 Biological Products, (No Diagnostic Substances)